Image Source: Unsplash

Cathie Wood’s ARK Invest made a major move on Friday. The fund purchased 350,734 shares of CoreWeave (CRWV), valued at roughly $24.27 million.

The timing is interesting. CoreWeave stock fell almost 22% over five trading sessions after the company cut its 2025 revenue outlook during its latest earnings call.

(Click on image to enlarge)

Wood appears to be betting on a recovery. This isn’t her first CoreWeave purchase either. ARK has been steadily adding to this position in recent weeks.

CoreWeave operates cloud infrastructure specifically designed for AI applications. The company has a market cap of $35.7 billion and trades on the NASDAQ.

The financial picture for CoreWeave is complicated. The company generates $4.3 billion in revenue but carries a net margin of -17.8%. Its debt-to-equity ratio sits at 4.85, reflecting heavy leverage.

The company’s gross margin of 73.85% shows strong product-level profitability. But operational efficiency remains weak with an operating margin of just 3.63%.

CoreWeave’s current ratio of 0.49 suggests potential liquidity problems. The interest coverage ratio of 0.16 indicates the company struggles to cover its interest expenses.

Insider activity has been negative. There have been 87 insider selling transactions over the past three months. Insider ownership stands at just 1.6%.

Crypto Plays During Market Pullback

ARK Invest didn’t stop at CoreWeave. The fund also increased its crypto exposure on Friday.

It bought 49,900 shares of Bullish. It added 31,890 shares of BitMine Immersion Technologies. The fund also picked up 20,700 shares of the ARK 21Shares Bitcoin ETF.

These purchases came as Bitcoin dropped below $85,000. This marks Bitcoin’s lowest level since April when it briefly fell below $75,000.

Wood seems to be applying her buy-the-dip strategy across multiple positions. The crypto purchases follow the same pattern as the CoreWeave buy.

ARK also added to its biotech holdings. The fund purchased 67,078 shares of CRISPR Therapeutics worth about $3.3 million. This continues ARK’s focus on gene-editing technology.

Trimming Tech Positions

On the selling side, ARK made several cuts. The largest was GitLab, where the fund sold 670,144 shares worth $28.49 million.

This wasn’t ARK’s first GitLab sale. The fund has been reducing this position over multiple trading sessions.

ARK also sold 227,153 shares of Exact Sciences. The sale was valued at roughly $22.87 million.

The fund cut 169,485 shares of Iridium, totaling about $2.68 million. It also made a smaller trim in Advanced Micro Devices, selling 1,623 shares worth about $334,370.

These sales appear to fund ARK’s purchases in CoreWeave and crypto assets. The fund is rotating capital from software and chipmakers into AI infrastructure and digital assets.

CoreWeave’s valuation metrics show a P/S ratio of 6.65 and a P/B ratio of 9.2. The RSI reading of 21.07 suggests the stock is oversold.

Institutional ownership in CoreWeave stands at 44.21%. Analyst recommendations average at 2.5, indicating a hold position.

More By This Author: